• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1012016-150
Device Problems Mechanical Jam (2983); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/18/2022
Event Type  malfunction  
Manufacturer Narrative
The device was returned for analysis.The reported activation/deployment failure was able to be confirmed.The stent was exposed for a length of 2mm.The reported mechanical jam was unable to be tested due to the condition of the returned device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It is possible that inadvertent mishandling resulted in the noted crack on the stabilizer adjacent to the strain relief, thus restricting the shaft lumens from moving freely and thus preventing the thumbwheel from rotating resulting in the reported mechanical jam and the reported activation/deployment failure; however this cannot be confirmed.Manipulation of the device and thumbwheel likely resulted in the noted device damages (wrinkled sheath, smashed spool axel).There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure to treat a lesion in the right superior femoral artery (sfa) with heavy calcification and moderate tortuosity.A 7.0 x 150mm absolute pro self-expanding stent system (sess) was advanced to the target lesion.However, when attempting stent deployment, there was resistance when attempting to advance the thumbwheel.The thumbwheel would not turn and the stent could not be deployed; and therefore the sess was removed from the patient and the procedure was completed with an unspecified absolute pro sess.There was no adverse patient effects and no clinically significant delays in the procedure.No additional information was provided.The returned device analysis revealed that the stent was exposed for a length of 2mm.
 
Manufacturer Narrative
The device was returned for analysis.The reported activation/deployment failure was able to be confirmed.The reported mechanical jam was unable to be tested due to the condition of the returned device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.It is possible that inadvertent mishandling resulted in the noted crack on the stabilizer adjacent to the strain relief, thus restricting the shaft lumens from moving freely and thus preventing the thumbwheel from rotating resulting in the reported mechanical jam and the reported activation/deployment failure; however this cannot be confirmed.Manipulation of the device and thumbwheel likely resulted in the noted device damages (wrinkled sheath, smashed spool axel).There is no indication of a product quality issue with respect to manufacture, design or labeling.Although the difficulties encountered appear to be related to procedural circumstances, on may 11th, 2022, abbott determined that a field safety notice (fsn) was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.H6: investigation conclusion code 4315 was removed.
 
Event Description
Subsequent to the original filing, on may 11th, 2022, abbott determined that a field safety notice was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14045526
MDR Text Key288820667
Report Number2024168-2022-03698
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup
Report Date 06/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/07/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1012016-150
Device Lot Number1091561
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/02/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberUNK
Patient Sequence Number1
-
-